The current coronavirus 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome-coronavirus 2 (SARS-CoV-2) infection, raises important questions as to whether …

Asthma is a common inflammatory airway disease for which the most commonly used
controller medications are inhaled corticosteroids (ICS). Asthma control is difficult to achieve …

Inhaled corticosteroid (ICS) use is associated with an increased risk of pneumonia. This
study was performed to determine if ICS use is associated with an increased risk of …

Background Asthma exacerbations are frightening for patients and are occasionally fatal.
We tested the concept that a plan for patients to manage their asthma (self-management …

Background Asthma pathophysiology and treatment responsiveness are predicted by
inflammatory phenotype. However, the relationship between airway microbiology and …

Die vorliegende Leitlinie umfasst ein neues und aktualisiertes Konzept der Behandlung und
Prävention von erwachsenen Patienten mit ambulant erworbener Pneumonie und löst die …

Background Little is known about the relative risk of common bacterial, viral, fungal, and
parasitic infections in the general population of individuals exposed to systemic …

Background Severe and uncontrolled asthma is associated with increased risk of
exacerbations and death. A substantial proportion of asthma patients have poor asthma …

Glucocorticosteroids (GCS) are used on a daily basis to reduce airway inflammation in
asthma and chronic obstructive pulmonary disease (COPD). This treatment is usually …

Inhaled corticosteroids (ICS) could increase both the risk of coronavirus disease 2019
(COVID-19) and experiencing poor outcomes. To compare the clinical outcomes between …